About Us
InnoTherapix transforms scientific innovation into scalable, transfer-ready biopharmaceutical technologies.
Vision
To be a globally recognized source of transfer-ready biopharmaceutical technologies.
Mission
To integrate biotechnology R&D, regulatory strategy, specialized sourcing, and technology transfer to help pharmaceutical manufacturers and technology sponsors convert promising concepts into scalable, quality-driven, and commercially actionable solutions.
Core Values
Scientific integrity and evidence
Base decisions and claims on reproducible data; state limitations clearly; document assumptions and results.
Enterprise Technology
Design projects with quality, safety, data integrity, and applicable regulatory expectations from the outset.
Business Innovation
Work transparently and disciplines while protecting confidential information and IP.
Our Foundation
InnoTherapix was founded by Dr. Mohammad Soltany, a pharmaceutical biotechnology professional with a PharmD, PhD, MBA, and DBA and more than 15 years of experience across biopharmaceutical development, manufacturing, and business leadership. His expertise in biosimilars, mammalian cell-line development, peptide technologies, regulatory planning, and technology transfer provides the scientific and strategic foundation for every InnoTherapix project.
Meet the InnoTherapix Team
Our multidisciplinary team combines scientific expertise, development strategy, and industry experience to advance biopharmaceutical projects from concept to technology transfer.
Dr. Mohammad Soltany
Founder & Managing Director
Leads corporate strategy, partnerships, and the development of transfer-ready biopharmaceutical technologies.
Dr. Mohammad Soltany
Cell-Line Development Scientist
Develops and characterizes mammalian expression systems for biosimilar and recombinant biotherapeutic products.
Dr. Negar Mottaghi
AI & Antibody Engineering Scientist
Supports antibody humanization, sequence optimization, developability assessment, and biobetter design.
Dr. Neo
Biosensors
Supports technologies related to biosensors and AI-based wearable medical devices, especially CGM devices.